PET/CT: Combining Function and Morphology
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 49)
KeywordsPositron Emission Tomography Positron Emission Tomography Imaging Radiation Treatment Planning Positron Emission Tomogra Ammonia Positron Emission Tomography
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- ACS ACS: Cancer Facts & Figures 2001. American Cancer Society, National Home Office, Atlanta, pp 1–44Google Scholar
- Burger I, Goerres GW, Von Schulthess GK, et al. (2002b) PET/CT: Diagnostic improvement in recurrent colorectal carcinoma compared to PET alone. Radiology 225:424Google Scholar
- Ciernik IF, Dizendorf E, Baumert BG, et al. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. International Journal of Radiation Oncology Biology Physics 57:853–863Google Scholar
- Goerres GW, Schmid DT, von Schulthess GK, et al. (2003) FDG PET/CT improves the confidence of anatomic assignment of cancer lesions in the head and neck: a comparison with FDG PET and contrast-enhanced CT. J Nucl Med 44:417–zzzGoogle Scholar
- Goldberg RM, Fleming TR, Tangen CM, et al. (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27–35PubMedGoogle Scholar
- Jaszczak RJ, Hoffman ED (1995) Positron Emission Tomography (PET): scatter and attenuation, in Wagner HN, Szabo Z, Buchanan JW (eds): Principles of nuclear medicine, 2nd edn. WB Saunders, PhiladelphiaGoogle Scholar
- Jerusalem G, Beguin Y, Fassotte MF, et al. (1999) Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94:429–433PubMedGoogle Scholar
- Schaefer NG, Hany TF, Taverna C, et al. (2003) FDG PET/CT versus contrast enhanced CT in aggressive non-Hodgkin lymphoma and Hodgkin’s disease. J Nucl Med 44:272Google Scholar
© Springer-Verlag Berlin Heidelberg 2005